Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Poland Non-Small Cell Lung Cancer Market: By Molecular Test, By Collection Type, By Cancer Type, and Country
Poland Non-Small Cell Lung Cancer Market: By Molecular Test, By Collection Type, By Cancer Type, and Country
| 1. Executive Summary |
| 2. Poland Non-Small Cell Lung Cancer (NSCLC) Market Introduction |
| 2.1. Poland Non-Small Cell Lung Cancer (NSCLC) Market Taxonomy |
| 2.2. Poland Non-Small Cell Lung Cancer (NSCLC) Market Definitions |
| 2.2.1. Molecular Test |
| 2.2.2. Collection Type |
| 2.2.3. Cancer Type |
| 3. Poland Non-Small Cell Lung Cancer (NSCLC) Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Collaborations, Acquisitions and Mergers |
| 3.6. Poland Non-Small Cell Lung Cancer (NSCLC) Market Competition Landscape |
| 3.7. Poland Non-Small Cell Lung Cancer (NSCLC) Market Dynamic Factors - Impact Analysis |
| 4. Poland Non-Small Cell Lung Cancer (NSCLC) Market Analysis, 2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Poland Non-Small Cell Lung Cancer (NSCLC) Market, By Molecular Test Platform, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 5.1. PCR |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. NGS |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. FISH |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. IHC |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Poland Non-Small Cell Lung Cancer (NSCLC) Market Forecast, By Collection Type, 2019-2023 and Forecast, 2024-2030 |
| 6.1. Mediastinoscopy |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Bronchoscopy |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Needle Biopsy |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Poland Non-Small Cell Lung Cancer (NSCLC) Market Forecast, By Cancer Type, 2019-2023 and Forecast, 2024-2030 |
| 7.1. Adenocarcinoma |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Squamous Cell Carcinoma |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Large Cell Carcinoma |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Adenosquamous Carcinoma |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, US$ Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Research Methodology |
| 9. Key Assumptions and Acronyms |
|
Report Benchmarks |
Details |
|
By Molecular Test |
|
|
By Collection Type |
|
|
By Cancer Type |
|
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.